PLOS Medicine publishes research and commentary of general interest with clear implications for patient care, public policy or clinical research agendas.
Post a new comment on this article
Reporting Bias in Drug Trials Submitted to the Food and Drug Administration:
Review of Publication and Presentation
Ambra 2.10.20 Managed Colocation provided by Internet Systems Consortium.
Send us feedback
Help using this site